TrialJournal of immunology (Baltimore, Md. : 1950)2008

Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant.

Sylvia Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.